SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
134 hedge funds and large institutions have $1.15B invested in Sage Therapeutics in 2015 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
40% less capital invested
Capital invested by funds: $1.93B → $1.15B (-$777M)
Holders
134
Holding in Top 10
5
Calls
$10.7M
Puts
$4.7M
Top Buyers
| 1 | +$36.1M | |
| 2 | +$14.7M | |
| 3 | +$14.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.5M |
Top Sellers
| 1 | -$98.6M | |
| 2 | -$35M | |
| 3 | -$5.84M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$4.77M |
| 5 |
Two Sigma Investments
New York
|
-$2.79M |